CorMedix Inc. (MUN:19KA) Financings

CorMedix Inc.

Financings

RaiseDate
Convertible debt
Closed: US$150M raised
Buyers: Deerfield
Use of proceeds: Funding the cash consideration for the acquisition of Melinta Therapeutics
Sep 2, 2025
Public offering of shares of common stock
Update: about US$85M · RBC Capital Markets +3
Dealers: RBC Capital Markets (lead), Truist Securities, Citizens Capital Markets, Needham & Company
Use of proceeds: General corporate purposes, including working capital, research and product candidate development, and potential strategic transactions
Jun 27, 2025

Read by 6ix AI from the company's releases